Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512902
Status:
COMPLETED
Last Update Posted:
2014-10-27
First Post:
2007-08-06
Brief Title:
A Study Using The Experimental Drug Called Imatinib Gleevec in Subjects With Systemic Sclerosis
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Organization Data
Organization:
University of California Los Angeles
Class:
OTHER
Study ID:
CST1571EUS210
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of California Los Angeles
Lead Sponsor Class:
OTHER
Responsible Party:
Daniel Furst
Responsible Party Title:
MD Carl M Pearson Professor of Rheumatology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of California Los Angeles
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Pharmaceuticals | INDUSTRY |